Amplification of the Gp41 gene for detection of mutations conferring resistance to HIV-1 fusion inhibitors on genotypic assay

1st Physics and Technologies in Medicine and Dentistry Symposium

物理学;医药卫生

Tanumihardja, J.^1 ; Bela, B.^1

Department of Microbiology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia^1

关键词: Amplification products;    Control program;    Fusion inhibitors;    Indonesia;    Optimal annealing;    Plasma samples;    Sensitivity and specificity;    Target genes;   

Others  :  https://iopscience.iop.org/article/10.1088/1742-6596/884/1/012143/pdf
DOI  :  10.1088/1742-6596/884/1/012143

学科分类：卫生学

来源: IOP

【 摘 要 】

Fusion inhibitors have potential for future use in HIV control programs in Indonesia, so the capacity to test resistance to such drugs needs to be developed. Resistance-detection with a genotypic assay began with amplification of the target gene, gp41. Based on the sequence of the two most common HIV subtypes in Indonesia, AE and B, a primer pair was designed. Plasma samples containing both subtypes were extracted to obtain HIV RNA. Using PCR, the primer pair was used to produce the amplification product, the identity of which was checked based on length under electrophoresis. Eleven plasma samples were included in this study. One-step PCR using the primer pair was able to amplify gp41 from 54.5% of the samples, and an unspecific amplification product was seen in 1.1% of the samples. Amplification failed in 36.4% of the samples, which may be due to an inappropriate primer sequence. It was also found that the optimal annealing temperature for producing the single expected band was 57.2 °C. With one-step PCR, the designed primer pair amplified the HIV-1 gp41 gene from subtypes AE and B. However, further research should be done to determine the conditions that will increase the sensitivity and specificity of the amplification process.